Global audio specialist and Formula E join forces in a multi-year partnership to shape the future of immersive motorsport experiences
LONDON, Aug. 11, 2026 /PRNewswire/ -- Formula E and Sennheiser have today announced a multi-year partnership under which Sennheiser, the world-renowned audio specialist, will become Formula E's Official Sound Provider. The collaboration will see the ABB FIA Formula E World Championship integrate Sennheiser's professional audio solutions and pioneering AMBEO immersive audio technology across the global series, creating new ways for fans to experience the excitement, energy and emotion of electric racing.
As the first all-electric FIA World Championship, Formula E continues to lead the way in sport-tech innovation. Through this partnership, Formula E and Sennheiser will explore how advanced audio capture and encoding workflows can create more immersive experiences for viewers watching on any device. By partnering with Sennheiser, the series aims to set a new global benchmark for live sports broadcasting and fan engagement, utilising Sennheiser's expertise to capture the unique, high-performance soundscapes of the GEN4 era.
"Innovation and technology are at the core of Formula E, and Sennheiser is the perfect partner to help us redefine the audio landscape of our championship," says Dan Cherowbrier, CTO, Formula E. "Their professional audio technologies and workflows, particularly the AMBEO immersive ecosystem, provide a uniquely dynamic setting to explore the future of sound in racing. This collaboration is a vital proof point in how we connect real-world audio innovation with practical application, bringing fans closer to the action through natural, three-dimensional sound."
"Formula E represents exactly the kind of environment where meaningful innovation happens," says Andreas Sennheiser, CEO of the Sennheiser Group. "At Sennheiser, we are driven by the ambition to bring advanced audio technologies into real-world applications, and this collaboration gives us an exciting opportunity to rethink the role sound can play in electric racing. Great visuals deserve equally compelling sound, and we see real potential to define the sport's unique acoustic character through dynamic in-car and trackside soundscapes. Ultimately, this partnership is about learning, exploring and helping to shape the future of how live sport is experienced."
The technical partnership focuses on deep integration within Formula E's broadcast and trackside operations. A key innovation driver for this collaboration is AMBEO, Sennheiser's immersive audio technology and solutions ecosystem. "AMBEO enables the capture, processing and reproduction of natural, three-dimensional sound, supporting more immersive and emotionally engaging listening experiences," concludes Kai Detlefsen, Manager, AMBEO at Sennheiser. "Within Formula E, AMBEO solutions will allow viewers at home to feel more closely connected to the dynamic racing environment and to their favourite teams."
Beyond the broadcast, the partnership will also enhance Formula E's onsite fan zones and VIP hospitality, ensuring that the Championship remains the most cutting-edge experience in sports entertainment.
The high-resolution images accompanying this media release can be downloaded here.
Sennheiser, Formula E & ABB boilerplate
Sennheiser is now the Official Sound Provider of Formula E
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Sennheiser becomes Official Sound Provider of Formula E
- PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansion
CHUNCHEON, South Korea, Aug. 11, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based, functional K-dermocosmetics that prioritize efficacy and safety.
Developed through advanced biomaterial technology and university R&D, DAYNICS is dedicated to restoring the skin's inherent health. Moving beyond basic moisturization, the brand offers a multifunctional derma-care solution designed to support skin barrier care, renewal, conditioning, soothing, and antioxidant protection.
The flagship product, DAYNICS PDRN-Madeca Derma Cream, features plant-derived polydeoxyribonucleotide (PDRN), madecassoside, and N-Caffeoyl Tyramine (NCT)—a patented ingredient independently developed by K-Medichem. Plant-derived PDRN supports skin regeneration, tissue recovery, and barrier reinforcement. Madecassoside, derived from Centella asiatica, helps soothe skin sensitized by external stimuli. Furthermore, K-Medichem's proprietary NCT protects the skin from oxidative stress caused by UV exposure and fine dust through powerful antioxidant activity. These three key ingredients work synergistically in a skin-friendly formulation to provide intensive moisturization, soothing care, and skin-renewal support.
Complementing the cream, K-Medichem has launched the DAYNICS PDRN-Madeca Derma Serum and DAYNICS PDRN-Madeca Derma Serum Mask to complete its premium skincare lineup. The serum delivers concentrated active ingredients for intensive nourishment, while the mask serves as an intensive-care treatment for targeted hydration and barrier recovery. Together, these products form a comprehensive daily skincare routine.
As an R&D-focused enterprise, K-Medichem continually commercializes university research outcomes into differentiated dermocosmetics. Building on this expertise, the company plans to steadily expand its distribution network across Southeast Asia and into broader global markets.
"DAYNICS is a premium bio-derma skincare brand developed on the basis of advanced technology and patented functional ingredients," said a K-Medichem representative. "We will continue to expand our PDRN Derma lineup, strengthen cooperation with local distribution partners, and grow DAYNICS into a trusted K-derma brand globally."
1. Official Website
http://www.skinmedichem.co.kr/
2. Instagram
https://www.instagram.com/kmedichem
3. YouTube
https://www.youtube.com/@Kmedichem
CHUNCHEON, South Korea, Aug. 11, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is accelerating its sales expansion across Vietnam, Indonesia, and other global markets with the PDRN skincare range from its premium brand, DAYNICS. With interest in skin-barrier and sensitive skin care surging across Southeast Asia, K-Medichem aims to strengthen its global strategy by delivering science-based, functional K-dermocosmetics that prioritize efficacy and safety.
Developed through advanced biomaterial technology and university R&D, DAYNICS is dedicated to restoring the skin's inherent health. Moving beyond basic moisturization, the brand offers a multifunctional derma-care solution designed to support skin barrier care, renewal, conditioning, soothing, and antioxidant protection.
The flagship product, DAYNICS PDRN-Madeca Derma Cream, features plant-derived polydeoxyribonucleotide (PDRN), madecassoside, and N-Caffeoyl Tyramine (NCT)—a patented ingredient independently developed by K-Medichem. Plant-derived PDRN supports skin regeneration, tissue recovery, and barrier reinforcement. Madecassoside, derived from Centella asiatica, helps soothe skin sensitized by external stimuli. Furthermore, K-Medichem's proprietary NCT protects the skin from oxidative stress caused by UV exposure and fine dust through powerful antioxidant activity. These three key ingredients work synergistically in a skin-friendly formulation to provide intensive moisturization, soothing care, and skin-renewal support.
Complementing the cream, K-Medichem has launched the DAYNICS PDRN-Madeca Derma Serum and DAYNICS PDRN-Madeca Derma Serum Mask to complete its premium skincare lineup. The serum delivers concentrated active ingredients for intensive nourishment, while the mask serves as an intensive-care treatment for targeted hydration and barrier recovery. Together, these products form a comprehensive daily skincare routine.
As an R&D-focused enterprise, K-Medichem continually commercializes university research outcomes into differentiated dermocosmetics. Building on this expertise, the company plans to steadily expand its distribution network across Southeast Asia and into broader global markets.
"DAYNICS is a premium bio-derma skincare brand developed on the basis of advanced technology and patented functional ingredients," said a K-Medichem representative. "We will continue to expand our PDRN Derma lineup, strengthen cooperation with local distribution partners, and grow DAYNICS into a trusted K-derma brand globally."
1. Official Website
http://www.skinmedichem.co.kr/
2. Instagram
https://www.instagram.com/kmedichem
3. YouTube
https://www.youtube.com/@Kmedichem
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond
